Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Mise à jour : Il y a 7 ans
Référence : NCT00963105

Femme et Homme

Extrait

The purpose of this study is to determine the safety and effectiveness of different dose regimen of lenalidomide in patients with relapsed or refractory chronic lymphocytic leukemia.


Critère d'inclusion

  • Relapsed or Refractory Chronic Lymphocytic Leukemia


Liens